Template:DrugProjectForm: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
|postmarketing= | |postmarketing= | ||
|drugInteractions= | |drugInteractions= | ||
|hasUsageInfo= | |||
|hasUseInPregnancyFDA= | |hasUseInPregnancyFDA= | ||
|useInPregnancyFDA= | |useInPregnancyFDA= | ||
| Line 199: | Line 200: | ||
}} | }} | ||
{{#if: {{{ | {{#if: {{{hasUsageInfo|}}} | | ||
==Use in Specific Populations== | ==Use in Specific Populations== | ||
'''Below is the code to be placed on the Drug Interaction Microchapter:''' | '''Below is the code to be placed on the Drug Interaction Microchapter:''' | ||
| Line 214: | Line 215: | ||
<nowiki>: '''[[Pregnancy category#United States|Pregnancy Category (FDA)]]'''</nowiki> | <nowiki>: '''[[Pregnancy category#United States|Pregnancy Category (FDA)]]'''</nowiki> | ||
{{{useInPregnancyFDA}}} | {{#if: {{{hasUseInPregnancyFDA|}}} | | ||
{{{useInPregnancyFDA}}} | | |||
<nowiki>There is no FDA guidance on usage of {{BASEPAGENAME}} in women who are pregnant.</nowiki> | |||
}} | |||
<nowiki>:'''[[Pregnancy category#Australia|Pregnancy Category (AUS)]]'''</nowiki> | <nowiki>:'''[[Pregnancy category#Australia|Pregnancy Category (AUS)]]'''</nowiki> | ||
{{{ | {{#if: {{{hasUseInPregnancyAus|}}} | | ||
{{{useInPregnancyAus}}} | | |||
<nowiki>There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{BASEPAGENAME}} in women who are pregnant.</nowiki> | |||
}} | |||
<nowiki>===Labor and Delivery===</nowiki> | <nowiki>===Labor and Delivery===</nowiki> | ||
{{{useInLaborDelivery}}} | {{#if: {{{hasUseInLaborDelivery|}}} | | ||
{{{useInLaborDelivery}}} | | |||
<nowiki>There is no FDA guidance on use of {{BASEPAGENAME}} during labor and delivery.</nowiki> | |||
}} | |||
<nowiki>===Nursing Mothers===</nowiki> | <nowiki>===Nursing Mothers===</nowiki> | ||
{{{useInNursing}}} | {{#if: {{{hasUseInNursing|}}} | | ||
{{{useInNursing}}} | | |||
<nowiki>There is no FDA guidance on the use of {{BASEPAGENAME}} in women who are nursing.</nowiki> | |||
}} | |||
<nowiki>===Pediatric Use===</nowiki> | <nowiki>===Pediatric Use===</nowiki> | ||
{{{useInPed}}} | {{#if: {{{hasUseInPed|}}} | | ||
{{{useInPed}}} | | |||
<nowiki>There is no FDA guidance on the use of {{BASEPAGENAME}} in pediatric settings.</nowiki> | |||
}} | |||
<nowiki>===Geriatic Use===</nowiki> | <nowiki>===Geriatic Use===</nowiki> | ||
{{{useInGeri}}} | {{#if: {{{hasUseInGer|}}} | | ||
{{{useInGeri}}} | | |||
<nowiki>There is no FDA guidance on the use of {{BASEPAGENAME}} in geriatric settings.</nowiki> | |||
}} | |||
<nowiki>===Gender===</nowiki> | <nowiki>===Gender===</nowiki> | ||
{{{useInGender}}} | {{#if: {{{hasUseInGender|}}} | | ||
{{{useInGender}}} | | |||
<nowiki>There is no FDA guidance on the use of {{BASEPAGENAME}} with respect to specific gender populations.</nowiki> | |||
}} | |||
<nowiki>===Race===</nowiki> | <nowiki>===Race===</nowiki> | ||
{{{useInRace}}} | {#if: {{{hasUseInRace|}}} | | ||
{{{useInRace}}} | | |||
<nowiki>There is no FDA guidance on the use of {BASEPAGENAME}} with respect to specific racial populations.</nowiki> | |||
}} | |||
<nowiki>===Renal Impairment===</nowiki> | <nowiki>===Renal Impairment===</nowiki> | ||
{{{useInRenalImpair}}} | {{#if: {{{hasUseInRenalImpair|}}} | | ||
{{{useInRenalImpair}}} | | |||
<nowiki>There is no FDA guidance on the use of {{BASEPAGENAME}} in patients with renal impairment.</nowiki> | |||
}} | |||
<nowiki>===Hepatic Impairment===</nowiki> | <nowiki>===Hepatic Impairment===</nowiki> | ||
{{{useInHepaticImpair}}} | {{#if: {{{hasUseInHepaticImpari|}}} | | ||
{{{useInHepaticImpair}}} | | |||
<nowiki>There is no FDA guidance on the use of {{BASEPAGENAME}} in patients with hepatic impairment.</nowiki> | |||
}} | |||
<nowiki>===Females of Reproductive Potential and Males===</nowiki> | <nowiki>===Females of Reproductive Potential and Males===</nowiki> | ||
{{{useInReproPotential}}} | {{#if: {{{hasUseInReproPotential|}}} | | ||
{{{useInReproPotential}}} | | |||
<nowiki>There is no FDA guidance on the use of {{BASEPAGENAME}} in women of reproductive potentials and males.</nowiki> | |||
}} | |||
<nowiki>===Immunocompromised Patients===</nowiki> | <nowiki>===Immunocompromised Patients===</nowiki> | ||
{{{useInImmunocomp}}} | {{#if: {{{hasImmunocomp|}}} | | ||
{{{useInImmunocomp}}} | | |||
<nowiki>There is no FDA guidance one the use of {{BASEPAGENAME}} in patients who are immunocompromised.</nowiki> | |||
}} | |||
<nowiki>{{DrugReflist}}</nowiki></div> | <nowiki>{{DrugReflist}}</nowiki></div> | ||
Revision as of 14:03, 19 March 2014
This is the "Drug Project Form" template. It should be called in the following format:
{{DrugProjectForm
|hasBlackBoxWarning=
|blackBoxWarningTitle=
|blackBoxWarningBody=
|fdaLIADAdult=
|offLabelAdult=
|fdaLIADPed=
|offLabelPed=
|contraindications=
|warnings=
|adverseReactions=
|clinicalTrials=
|postmarketing=
|drugInteractions=
|hasUsageInfo=
|hasUseInPregnancyFDA=
|useInPregnancyFDA=
|hasUseInPregnancyAUS=
|useInPregnancyAUS=
|hasUseInLaborDelivery=
|useInLaborDelivery=
|hasUseInNurshing=
|useInNursing=
|hasUseInPed
|useInPed=
|hasUseInGeri=
|useInGeri=
|hasUseInGender
|useInGender=
|hasUseInRace
|useInRace=
|hasUseInRenalImpair=
|useInRenalImpair=
|hasUseInHepaticImpair=
|useInHepaticImpair=
|hasUseInReproPotential=
|useInReproPotential=
|hasUseInImmunocomp=
|useInImmunocomp=
|routes=
|preparations=
|IVCompat=
|overdose=
|mechAction=
|structure=
|PD=
|PK=
|nonClinToxic=
|clinicalStudies=
|howSupplied=
|drugImages=
|packLabel=
|fdaPatientInfo=
|nlmPatientInfo=
|price=
|drugShortage=
}}
Edit the page to see the template text.